Metal artifact reduction and contrast agent performance as a function of source spectral shape
<i>Objective.</i>Empirically map the x-ray source of a Medipix All Resolution Scanner (MARS) photon counting CT (PCCT) with Cu and Sn pre-filters, assess metal artifact reduction (MAR) capabilities of these pre-filters, and measure pre-filtration impact on contrast performance (CP) of FDA approved iopromide and experimental tantalum oxide nanoparticles (TaO<i><sub>x</sub></i>NPs).<i>Approach.</i>The x-ray source of a MARS-PCCT system was empirically mapped with no pre-filtration, seven Cu filters (0.3-2.1 mm), and seven Sn filters (0.15-1.05 mm). A phantom with inserts containing water, lipid, iopromide, TaO<i><sub>x</sub></i>NPs, and metal was scanned with no pre-filtration and Cu and Sn pre-filters. Insert noise, signal, contrast-to-pooled-noise ratio (CPNR), and a fast Fourier transform artifact metric (FFTAM) were calculated for each filter to quantify MAR and CP.<i>Main results.</i>Thick filters for Cu and Sn shifted mean energy of the unfiltered x-ray source (47.9 keV) by 19.2 and 23.4 keV, respectively. Thick filtration, 2.1 mm Cu and 0.6 mm Sn, greatly reduced noise (up to 74%) and FFTAM (up to 71%) for all inserts and energy bins. Thin filtration, 0.3 mm Cu and 0.15 mm Sn, also reduced noise (up to 47%) and FFTAM (up to 41%). In most cases, iopromide lost significant contrast (up to 50%). TaO<i><sub>x</sub></i>NPs also lost contrast, though to a lesser extent (up to 38%). Pre-filtration improved image efficacy (i.e. CPNR), especially for TaO<i><sub>x</sub></i>(up to 61%).<i>Significance.</i>By empirically mapping the source spectrum of a MARS-PCCT system with pre-filters, valuable information was gathered about photon flux distribution and detector artifacts; these findings will prove insightful for applications such as energy binning for effective material decomposition. Furthermore, this information will potentially guide clinical MAR development, most notably for the MARS Extremity 5 × 120 recently deployed for first-in-human trials. Lastly, TaO<i><sub>x</sub></i>NPs were shown to be more compatible than iopromide with spectral shaping.
Authors
- Peter J. Bonitatibus (ORCID: https://orcid.org/0000-0002-6650-9059)
- Ge Wang (ORCID: https://orcid.org/0000-0002-2656-7705)
- Jacob Daniel Aubrey (ORCID: https://orcid.org/0009-0009-6006-1087)
- Emmett Patrick Perkinson
Institutions
- Rensselaer Polytechnic Institute (US)
- Hudson Valley Community College (US)
Publication Details
- Journal
- Physics in Medicine and Biology
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1088/1361-6560/ae0be9
- Primary Topic
- Advanced X-ray and CT Imaging
- Type
- article
- Field-Weighted Citation Impact
- 0.00